Literature DB >> 11041279

Antidopaminergic effects of 1,2,3,4-tetrahydroisoquinoline and salsolinol.

L Antkiewicz-Michaluk1, J Michaluk, I Romańska, I Papla, J Vetulani.   

Abstract

Immediate behavioral and biochemical effects of single doses of 1,2,3,4-tetrahydroisoquinoline (TIQ, 50 mg/kg) and salsolinol (100 mg/kg), suspected of involvement in etiology of Parkinson's disease, were investigated. Apomorphine (0.25 mg/kg) or haloperidol (1 mg/kg) were administered to TIQ or salsolinol pretreated Wistar rats. In additional experiment the displacement of [3H]apomorphine by TIQ, salsolinol and dopamine receptor agonists and antagonists was tested. Both tetrahydroisoquinolines only slightly affected behavior and dopamine metabolism in naive rats, but very effectively abolished the behavioral and biochemical effects of apomorphine (hyperactivity, depression of striatal HVA level). The behavioral and biochemical effects of haloperidol were unchanged by administration of TIQ nor salsolinol. The tetrahydroisoquinolines displaced [3H]apomorphine from its binding sites with effectiveness comparable to that of dopamine. The results support the hypothesis that endogenous tetrahydroisoquinolines may play an important role in regulation of dopaminergic activity in non-senescent organisms.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11041279     DOI: 10.1007/s007020070049

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  14 in total

1.  An endogenous neuroprotectant substance, 1-methyl-1,2,3,4-tetrahydroisoquinoline (1MeTIQ), prevents the behavioral and neurochemical effects of cocaine reinstatement in drug-dependent rats.

Authors:  L Antkiewicz-Michaluk; M Filip; J Michaluk; I Romańska; E Przegaliński; J Vetulani
Journal:  J Neural Transm (Vienna)       Date:  2006-08-10       Impact factor: 3.575

Review 2.  A possible physiological role for cerebral tetrahydroisoquinolines.

Authors:  Jerzy Vetulani; Lucyna Antkiewicz-Michaluk; Irena Nalepa; Mario Sansone
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

3.  Locomotor stimulant effects of acute and repeated intrategmental injections of salsolinol in rats: role of mu-opioid receptors.

Authors:  Lucía Hipólito; María-José Sánchez-Catalán; Teodoro Zornoza; Ana Polache; Luis Granero
Journal:  Psychopharmacology (Berl)       Date:  2010-03       Impact factor: 4.530

4.  1-Methyl-1,2,3,4-tetrahydroisoquinoline antagonizes a rise in brain dopamine metabolism, glutamate release in frontal cortex and locomotor hyperactivity produced by MK-801 but not the disruptions of prepulse inhibition, and impairment of working memory in rat.

Authors:  Małgorzata Pietraszek; Jerzy Michaluk; Irena Romańska; Agnieszka Wasik; Krystyna Gołembiowska; Lucyna Antkiewicz-Michaluk
Journal:  Neurotox Res       Date:  2009-08-01       Impact factor: 3.911

5.  Both stereoselective (R)- and (S)-1-Methyl-1,2,3,4-tetrahydroisoquinoline enantiomers protect striatal terminals against rotenone-induced suppression of dopamine release.

Authors:  Lucyna Antkiewicz-Michaluk; Agnieszka Wąsik; Irena Romańska; Andrzej Bojarski; Jerzy Michaluk
Journal:  Neurotox Res       Date:  2010-11-11       Impact factor: 3.911

6.  Chronic salsolinol administration prevents the behavioral and neurochemical effects of L-DOPA in rats.

Authors:  Agnieszka Wąsik; Irena Romańska; Jerzy Michaluk; Lucyna Antkiewicz-Michaluk
Journal:  Neurotox Res       Date:  2015-02-25       Impact factor: 3.911

Review 7.  Salsolinol: an Unintelligible and Double-Faced Molecule-Lessons Learned from In Vivo and In Vitro Experiments.

Authors:  Magdalena Kurnik-Łucka; Pertti Panula; Andrzej Bugajski; Krzysztof Gil
Journal:  Neurotox Res       Date:  2017-10-23       Impact factor: 3.911

Review 8.  Mystic Acetaldehyde: The Never-Ending Story on Alcoholism.

Authors:  Alessandra T Peana; María J Sánchez-Catalán; Lucia Hipólito; Michela Rosas; Simona Porru; Federico Bennardini; Patrizia Romualdi; Francesca F Caputi; Sanzio Candeletti; Ana Polache; Luis Granero; Elio Acquas
Journal:  Front Behav Neurosci       Date:  2017-05-11       Impact factor: 3.558

9.  Tetrahydroisoquinoline derivatives: a new perspective on monoaminergic dysfunction in children with ADHD?

Authors:  Veit Roessner; Susanne Walitza; Franz Riederer; Regina Hünnerkopf; Aribert Rothenberger; Manfred Gerlach; Andreas Moser
Journal:  Behav Brain Funct       Date:  2007-12-10       Impact factor: 3.759

Review 10.  1-Methyl-1,2,3,4-tetrahydroisoquinoline, an endogenous amine with unexpected mechanism of action: new vistas of therapeutic application.

Authors:  Lucyna Antkiewicz-Michaluk; Agnieszka Wąsik; Jerzy Michaluk
Journal:  Neurotox Res       Date:  2013-05-30       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.